FYDINMI
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97864443
- Registration number
- 7364897
- Mark type
- Stylized text
- Filed
- 30 Mar 2023
- Published for opposition
- 06 Feb 2024
- Registered
- 23 Apr 2024
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Feb 2024 — PUBLISHED FOR OPPOSITION
- 17 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Dec 2023 — ASSIGNED TO EXAMINER
- 12 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Apr 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Apr 2023 — NEW APPLICATION ENTERED